The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: ApoE Genotype, ApoE Genotype Cardio IQ, Apolipoprotein E Genotype, Cardio IQ ApoE Genotype
Also known as: Cholesterol, LDL, LDL, LDL Cholesterol, Direct, Low Density Lipoprotein
Also known as: C-Reactive Protein, Cardio CRP, Cardio hs-CRP, CRP, High Sensitivity CRP, High-sensitivity C-reactive Protein, High-sensitivity CRP, Highly Sensitive CRP, hsCRP, Ultra-sensitive CRP
Also known as: Lipid Panel with Ratios (fasting), Lipid Profile with Ratios (fasting), Lipids
Also known as: Lipoprotein A, Lp (a), Lp(a)
Also known as: Ion Mobility, Cardio IQ Lipoprotein Fractionation, Ion Mobility , HDL Subfractions, IDL Subfractions, LDL Subfractions, Lipoprotein Fraction, Lipoprotein Fractionation, Lipoprotein Fractionation Ion Mobility Cardio IQ, Quest Diagnostics has replaced the VAP® Cholesterol Test with Lipoprotein Fractionation, Ion Mobility, Cardio IQ™ test
Also known as: Very Low-Density Lipoprotein Cholesterol, VLDL, VLDL-C
The CVD-4. High Cholesterol Testing panel contains 9 tests with 26 biomarkers.
Brief Description: The CVD-4 High Cholesterol Testing panel represents the most comprehensive assessment in the series of cardiovascular diagnostics. It is designed to provide an extensive evaluation of cardiovascular risk factors, including genetic predispositions, lipid profiles, inflammatory markers, and more. This panel includes the Cardio IQ™ ApoE Genotype, Apolipoprotein A1, Apolipoprotein B, Direct LDL, hs-CRP, a Lipid Panel with Ratios, Lipoprotein (A), Cardio IQ™ Lipoprotein Fractionation, Ion Mobility, LP PLA2 Activity, and VLDL Cholesterol.
Collection Method: Blood Draw
Specimen Type: Whole Blood and Serum
Test Preparation: Fasting for at least 12 hours is required.
The CVD-4 High Cholesterol Testing panel is typically ordered for individuals at high risk of cardiovascular disease or those with a complex history of heart-related issues. It is particularly useful for patients seeking a detailed analysis of their cardiovascular health, including genetic factors that might influence their treatment plan. The panel is also recommended for individuals who have not achieved their lipid management goals with conventional treatments or who have a family history of cardiovascular disease, providing a deep dive into the factors contributing to their cardiovascular risk.
Cardio IQ™ ApoE Genotype: Identifies ApoE gene variants, which can affect cholesterol metabolism and influence an individual's response to dietary fats, providing insights into personalized dietary and treatment strategies.
Apolipoprotein A1 and Apolipoprotein B: Measure levels of proteins associated with HDL and LDL cholesterol, offering insights into the balance of protective vs. atherogenic lipoproteins in the blood.
Direct LDL: Provides an accurate measurement of LDL cholesterol levels, crucial for assessing cardiovascular risk and guiding lipid-lowering therapy.
hs-CRP: A marker of inflammation, elevated levels of which are associated with an increased risk of cardiovascular events.
Lipid Panel with Ratios: Assesses total cholesterol, HDL, LDL, triglycerides, and important ratios, providing a comprehensive overview of lipid health.
Lipoprotein (A): Elevated levels of Lp(a) are an independent risk factor for cardiovascular disease, particularly atherosclerosis.
Cardio IQ™ Lipoprotein Fractionation, Ion Mobility: Offers detailed analysis of lipoprotein particle size and density, further refining cardiovascular risk assessment.
LP PLA2 Activity: Measures the activity of an enzyme associated with vascular inflammation and plaque instability, adding another layer to cardiovascular risk profiling.
VLDL Cholesterol: Evaluates VLDL levels, which are important for understanding triglyceride transport and potential plaque buildup in the arteries.
The CVD-4 High Cholesterol Testing panel can help detect and manage several conditions:
Atherosclerosis: Detailed lipid profiles, including particle size and genetic predispositions, help in assessing the risk and progression of plaque buildup in the arteries.
Genetic Lipid Disorders: The ApoE genotype test can identify genetic variations that influence lipid metabolism, aiding in the diagnosis of familial hypercholesterolemia and other genetic lipid disorders.
Inflammatory Cardiovascular Conditions: Markers like hs-CRP and LP PLA2 Activity provide insight into the role of inflammation in cardiovascular disease, guiding anti-inflammatory treatment strategies.
Healthcare professionals utilize the CVD-4 High Cholesterol Testing panel results to:
Personalize Treatment Plans: Incorporating genetic information and detailed lipid analysis allows for tailored dietary, lifestyle, and pharmacological interventions.
Monitor Therapy Efficacy: Regular testing can assess the effectiveness of treatment regimens and the need for adjustments, particularly in patients with complex lipid disorders or those at high cardiovascular risk.
The CVD-4 High Cholesterol Testing panel offers an unparalleled depth of analysis for assessing cardiovascular risk, incorporating genetic, lipid, and inflammatory markers. This panel is invaluable for individuals with significant cardiovascular risk factors, a history of heart disease, or those seeking a detailed understanding of their cardiovascular health. By providing a holistic view of cardiovascular risk factors, the CVD-4 panel enables healthcare providers to devise personalized and effective treatment strategies, ultimately leading to better patient outcomes and reduced risk of cardiovascular events.
We advise having your results reviewed by a licensed medical healthcare professional for proper interpretation of your results.